342 related articles for article (PubMed ID: 18674635)
1. A genotoxicity test system based on p53R2 gene expression in human cells: assessment of its reactivity to various classes of genotoxic chemicals.
Ohno K; Ishihata K; Tanaka-Azuma Y; Yamada T
Mutat Res; 2008 Oct; 656(1-2):27-35. PubMed ID: 18674635
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity test system based on p53R2 gene expression in human cells: examination with 80 chemicals.
Ohno K; Tanaka-Azuma Y; Yoneda Y; Yamada T
Mutat Res; 2005 Dec; 588(1):47-57. PubMed ID: 16236544
[TBL] [Abstract][Full Text] [Related]
3. Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells.
Mizota T; Ohno K; Yamada T
Mutat Res; 2011 Sep; 724(1-2):76-85. PubMed ID: 21704725
[TBL] [Abstract][Full Text] [Related]
4. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins.
Liu X; Kramer JA; Swaffield JC; Hu Y; Chai G; Wilson AG
Mutat Res; 2008 May; 653(1-2):63-9. PubMed ID: 18485802
[TBL] [Abstract][Full Text] [Related]
5. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
6. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
10. Sensitive detection of chemical-induced genotoxicity by the Cypridina secretory luciferase reporter assay, using DNA repair-deficient strains of Saccharomyces cerevisiae.
Ochi Y; Sugawara H; Iwami M; Tanaka M; Eki T
Yeast; 2011 Apr; 28(4):265-78. PubMed ID: 21456053
[TBL] [Abstract][Full Text] [Related]
11. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.
Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM
Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187
[TBL] [Abstract][Full Text] [Related]
12. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
[TBL] [Abstract][Full Text] [Related]
13. The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development.
Westerink WM; Stevenson JC; Horbach GJ; Schoonen WG
Mutat Res; 2010 Feb; 696(1):21-40. PubMed ID: 20006733
[TBL] [Abstract][Full Text] [Related]
14. The development of GADD45α luciferase reporter assays in human cells for assessing the genotoxicity of environmental pollutants.
Xin L; Wang J; Wu Y; Guo S
Toxicol Mech Methods; 2015 Feb; 25(2):136-42. PubMed ID: 25560476
[TBL] [Abstract][Full Text] [Related]
15. A stable and sensitive testing system for potential carcinogens based on DNA damage-induced gene expression in human HepG2 cell.
Zhang R; Niu Y; Du H; Cao X; Shi D; Hao Q; Zhou Y
Toxicol In Vitro; 2009 Feb; 23(1):158-65. PubMed ID: 19013231
[TBL] [Abstract][Full Text] [Related]
16. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
[TBL] [Abstract][Full Text] [Related]
17. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
18. EILATox-Oregon Workshop: blind study evaluation of Vitotox test with genotoxic and cytotoxic sample library.
Meriläinen J; Lampinen J
J Appl Toxicol; 2004; 24(5):327-32. PubMed ID: 15478175
[TBL] [Abstract][Full Text] [Related]
19. Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress.
van der Linden SC; von Bergh AR; van Vught-Lussenburg BM; Jonker LR; Teunis M; Krul CA; van der Burg B
Mutat Res Genet Toxicol Environ Mutagen; 2014 Jan; 760():23-32. PubMed ID: 24362253
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
